269 related articles for article (PubMed ID: 19670960)
1. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.
Chong BF; Mohan C
Expert Opin Ther Targets; 2009 Oct; 13(10):1147-53. PubMed ID: 19670960
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus.
Wang A; Guilpain P; Chong BF; Chouzenoux S; Guillevin L; Du Y; Zhou XJ; Lin F; Fairhurst AM; Boudreaux C; Roux C; Wakeland EK; Davis LS; Batteux F; Mohan C
Arthritis Rheum; 2010 Nov; 62(11):3436-46. PubMed ID: 20722038
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
5. Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.
Launay O; Paul S; Servettaz A; Roguet G; Rozenberg F; Lucht F; Lambert C; Presles E; Goulvestre C; Méritet JF; Galtier F; Dubray C; Lebon P; Weill B; Batteux F
Vaccine; 2013 Aug; 31(35):3492-501. PubMed ID: 23764537
[TBL] [Abstract][Full Text] [Related]
6. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB
Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138
[TBL] [Abstract][Full Text] [Related]
7. Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.
Biajoux V; Bignon A; Freitas C; Martinez V; Thelen M; Lima G; Jakez-Ocampo J; Emilie D; Llorente L; Balabanian K
J Transl Med; 2012 Dec; 10():251. PubMed ID: 23244336
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus.
Hanaoka H; Okazaki Y; Hashiguchi A; Yasuoka H; Takeuchi T; Kuwana M
Clin Exp Rheumatol; 2015; 33(6):863-70. PubMed ID: 26320881
[TBL] [Abstract][Full Text] [Related]
9. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
Devarapu SK; Kumar Vr S; Rupanagudi KV; Kulkarni OP; Eulberg D; Klussmann S; Anders HJ
Clin Immunol; 2016 Aug; 169():139-147. PubMed ID: 27392463
[TBL] [Abstract][Full Text] [Related]
10. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
Mirisola V; Zuccarino A; Bachmeier BE; Sormani MP; Falter J; Nerlich A; Pfeffer U
Eur J Cancer; 2009 Sep; 45(14):2579-87. PubMed ID: 19646861
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration.
Liu KK; Dorovini-Zis K
J Neuroimmunol; 2009 Oct; 215(1-2):49-64. PubMed ID: 19765831
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A
Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410
[TBL] [Abstract][Full Text] [Related]
14. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta.
Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M
Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839
[TBL] [Abstract][Full Text] [Related]
15. Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation.
Pello OM; Martínez-Muñoz L; Parrillas V; Serrano A; Rodríguez-Frade JM; Toro MJ; Lucas P; Monterrubio M; Martínez-A C; Mellado M
Eur J Immunol; 2008 Feb; 38(2):537-49. PubMed ID: 18200497
[TBL] [Abstract][Full Text] [Related]
16. B-cell-directed therapies in systemic lupus erythematosus.
Tieng AT; Peeva E
Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
[TBL] [Abstract][Full Text] [Related]
17. TLR4
Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
[TBL] [Abstract][Full Text] [Related]
18. A review on CXCR4/CXCL12 axis in oncology: no place to hide.
Domanska UM; Kruizinga RC; Nagengast WB; Timmer-Bosscha H; Huls G; de Vries EG; Walenkamp AM
Eur J Cancer; 2013 Jan; 49(1):219-30. PubMed ID: 22683307
[TBL] [Abstract][Full Text] [Related]
19. CXCL12/CXCR4 axis in tissue targeting and bone destruction in cancer and multiple myeloma.
Ooi LL; Dunstan CR
J Bone Miner Res; 2009 Jul; 24(7):1147-9. PubMed ID: 19419311
[No Abstract] [Full Text] [Related]
20. Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo.
Thoma G; Streiff MB; Kovarik J; Glickman F; Wagner T; Beerli C; Zerwes HG
J Med Chem; 2008 Dec; 51(24):7915-20. PubMed ID: 19053768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
